← Eichor
Study identifier: NCT07536152 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Antihistamine for Prevention of HTR After Blood Primed CPB

Condition: Blood Transfusion Associated Adverse Reactions  ·  Sponsor: Kasr El Aini Hospital

PhasePhase 4
Planned participants40
Who can joinAll sexes, 1 Year to 7 Years
Healthy volunteersNo

About this study

This study will be a randomized, double-blinded, placebo-controlled study conducted at a university hospital. Forty children undergoing elective repair of a congenital heart defect will be included. The patients will be randomly allocated (20 patients per group) to receive a single intravenous dose of combined chlorpheniramine or normal saline immediately after separation from CPB, before protamine administration.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Misr Universty for Scince and TechnologyGiza, October, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07536152